Chemistry and Biochemistry Fall Lecture Series
Paul Scola of Bristol-Myers Squibb research and development will present “The Discovery of BMS-650032; An NS3 Protease Inhibitor for the Treatment of Hepatitis C,” Monday, Sept. 27, at 3:30 p.m. in CHEM 144.
A reception will take place after the seminar in CHEM 105.
For more information, see http://chemistry.uark.edu/1690.htm or contact seminar chair Matt McIntosh, mcintosh@uark.edu
The event is open to the public.
Contacts
Jennifer Sims, editor
Chemistry and biochemistry
575-5198,
jssims@uark.edu